Cannabis Science History: What Was Actually Discovered?
Cannabis science history has several discovery dates. See how THC isolation, synthesis, receptor binding and anandamide answered different questions.
Professor High
Written by Professor High, our AI guide. See how we research and correct articles.
Cannabis science developed through separate discoveries: isolating compounds, identifying their structures, synthesizing them, and finding the receptors and body-made substances they interact with. A single name and date cannot do all those jobs.
Take the famous year 1964. Gaoni and Mechoulam’s THC paper described isolation, structure and partial synthesis. Their separate 1965 paper reported total synthesis. Those are different achievements, even before the story reaches a receptor or a brain.
The useful question is not just “Who discovered it?” It is “What did this experiment find?” That question turns a list of dates into a much better history—and helps you read today’s cannabis claims, too.
What do isolation, identification and synthesis mean?
They describe different kinds of work. Separating a compound from a mixture does not, by itself, reveal its full structure. Knowing that structure is not the same as making the compound in a laboratory.
| Research task | Plain-language question | What the answer does not automatically give you |
|---|---|---|
| Isolation | Can we separate this substance from the mixture? | Its complete molecular structure |
| Structural identification | How are its atoms connected and arranged? | A manufacturing method or a medical benefit |
| Synthesis | Can we make the compound through chemical reactions? | Proof of its effects in people |
| Receptor research | Does it interact with a particular biological target, and how? | A complete account of an experience or disease |
Partial synthesis starts with a related compound and changes it. Total synthesis builds the target through a synthetic route from simpler starting materials. Both can be important. Neither word is a synonym for “first extracted from a plant.”
What did Gaoni and Mechoulam report in 1964?
They reported isolating an active hashish constituent and assigning its structure. Their paper appeared in the Journal of the American Chemical Society, volume 86, pages 1646–1647. Its title also identifies the work as partial synthesis. The original first-page preview describes separating and purifying the constituent, while acknowledging earlier work on active substances whose characterization remained incomplete.
That is more precise than saying they “invented THC.” The substance was in the material they studied. The scientific achievement was establishing what that active constituent was.
It also gives credit to Yehiel Gaoni as well as Raphael Mechoulam. The original article lists both authors, with Gaoni first.
There is a human story behind the analytical language. In a 2007 interview in Addiction, Mechoulam recalled how improved separation methods and nuclear magnetic resonance, or NMR, helped the work. He also described preparing the compound from CBD. That is a later recollection by a participant, rather than a contemporaneous laboratory record.
In the same interview, he explained the older name Δ1-THC used by his group and the later Δ9-THC naming. An unfamiliar number in an old title is a reason to check its naming system before assuming it describes a different modern retail product.
Was there THC research before 1964?
Yes. The publication record alone rules out a story in which no one had worked on THC before then. Roger Adams and B. R. Baker published a 1940 paper about synthesizing a tetrahydrocannabinol with marihuana activity.
That title establishes earlier work. It does not, on its own, establish that the material was pure natural delta-9 THC, settle every structural question, or decide an all-purpose “first discovery” contest. Those stronger claims require the experiments, not just a citation.
This matters when discussing prohibition. US restrictions had their own history, including the 1937 Marihuana Tax Act and the 1970 Controlled Substances Act. But the existence of research during those decades means we should not describe them as a single 80-year scientific blank. Measuring how particular restrictions delayed particular findings would need further evidence.
Why does a separate 1965 synthesis paper matter?
It shows why “isolated and synthesized in 1964” is an incomplete summary. The 1965 publication, by Mechoulam and Gaoni, specifically reports total synthesis in its title. The 1964 title specifies partial synthesis.
The two titles distinguish partial from total synthesis; they do not award all-purpose first-discovery credit.
There is a second date trap. ACS lists 2002 online publication dates for these archived papers. Their print issues are from 1964 and 1965. Digitizing an old paper does not turn it into a new discovery.
Source scope: the 1964 discussion uses the original first-page preview; the 1940 and 1965 comparisons use verified publication records. They do not claim full experimental access.
Was the endocannabinoid system discovered in 1988?
1988 was a receptor-binding milestone, not the date every part of the system became known. Three papers show the difference particularly well.
| Year and original paper | What the researchers reported | Keep the boundary clear |
|---|---|---|
| 1988: Devane and colleagues | Specific cannabinoid-receptor binding in rat brain preparations | Binding evidence, not a human trial or a cloned receptor |
| 1990: Matsuda and colleagues | Cloning and functional expression of receptor cDNA | A genetic and functional advance, not the discovery of every body-made signal |
| 1992: Devane and colleagues | Isolation and characterization of anandamide from pig brain | A body-derived compound studied in laboratory assays, not a measurement of human bliss |
The 1988 experiment has a detail worth keeping: its labeled probe was the synthetic cannabinoid CP-55,940, not labeled plant THC. The researchers tested how it bound to rat brain preparations and how other compounds competed with it. The binding was saturable and reversible, with selectivity between chemical forms. Those observations supported a specific receptor rather than merely showing that a substance entered fatty tissue.
In 1990, Lisa Matsuda and colleagues reported the cloned genetic material and the function of the receptor it encoded. Finding evidence for a binding site and identifying a receptor’s genetic instructions are related, but different, accomplishments.

Selected milestones, not the whole history: rat-tissue binding, receptor cDNA, and a pig-brain compound. The symbols are conceptual illustrations, not molecular structures.
What did the original anandamide paper leave unanswered?
It did not claim to have established all of anandamide’s biological roles. The researchers identified the pig-brain compound through chemical analysis and synthesis, tested receptor binding, and measured a response in isolated mouse tissue.
Their original 1992 paper, reproduced on pages 347–350 of this state-hosted appendix, explicitly said the results did not yet establish anandamide as a neuromediator. They also could not firmly attribute the tissue response to the cannabinoid receptor. Those limits were part of the discovery itself.
“Anandamide was found” and “every function of anandamide was proved” are very different sentences. The first can mark a major advance while leaving years of useful work ahead.
Why does this history matter when reading cannabis claims?
It teaches you to match the claim to the experiment. A chemical structure answers an identity question. A receptor assay answers a biological-interaction question. Neither directly answers whether a particular product improves sleep, music, mood or performance in people.
That distinction still matters in our THC and CBD evidence comparison, the question of terpenes and music perception, and research on feeling creative versus measured creative output.
A good discovery headline tells you what changed. A good explanation also tells you what remained unknown.
Key takeaways
- Isolation, structural identification and synthesis are different achievements.
- The 1964 THC paper specifies partial synthesis; a separate 1965 paper reports total synthesis.
- Earlier THC publications make a “science started in 1964” story too simple.
- Receptor binding in 1988, cloning in 1990 and anandamide isolation in 1992 answered different questions.
- An original paper’s limits belong in its history, alongside its breakthrough.
FAQ
Did Raphael Mechoulam discover THC alone?
No. The 1964 paper was authored by Yehiel Gaoni and Raphael Mechoulam. Earlier researchers also published work on tetrahydrocannabinols, so the credit needs to specify the achievement being discussed.
Is partial synthesis the same as total synthesis?
No. Partial synthesis changes a related starting compound; total synthesis constructs the target through a synthetic route from simpler materials. Neither term means simply extracting a substance from cannabis.
Why do histories give both 1988 and 1990 for the cannabinoid receptor?
They refer to different milestones. The 1988 paper reported receptor binding in rat brain preparations; the 1990 paper reported cloning and functional expression of receptor cDNA.
Did the 1992 study find THC inside the body?
No. It identified a different compound, anandamide, from pig brain and tested its properties. Sharing a receptor-related research story does not make two substances chemically identical.